Macitentan attenuates cardiovascular remodelling in infant rats with chronic lung disease

BACKGROUND: Cardiovascular impairment contributes to increased mortality in preterm infants with chronic lung disease. Macitentan, an endothelin-1 receptor antagonist, has the potential to attenuate pulmonary and cardiovascular remodelling. METHODS: In a prospective randomized placebo-controlled int...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumann, Philipp, Greco, Francesco, Wiegert, Susanne, Wellmann, Sven, Pellegrini, Giovanni, Cannizzaro, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818179/
https://www.ncbi.nlm.nih.gov/pubmed/35123510
http://dx.doi.org/10.1186/s12967-022-03281-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818179/
https://www.ncbi.nlm.nih.gov/pubmed/35123510
http://dx.doi.org/10.1186/s12967-022-03281-2

Ejemplares similares